Clarinex-D and Daclizumab Subcutaneous
Determining the interaction of Clarinex-D and Daclizumab Subcutaneous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: desloratadine / pseudoephedrine
Brand name: Clarinex-D 12 Hour, Clarinex-D 24 Hour
Synonyms: Desloratadine and pseudoephedrine
Generic Name: daclizumab
Brand name: Zinbryta, Zenapax
Synonyms: Daclizumab
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Clarinex-D-Dacogen
- Clarinex-D-Dacomitinib
- Clarinex-D-Dactinomycin
- Clarinex-D-Dactinomycin Injection
- Clarinex-D-Dactinomycin Intravenous
- Clarinex-D-Daklinza
- Daclizumab Subcutaneous-Clarinex-D 12 Hour
- Daclizumab Subcutaneous-Clarinex-D 24 Hour
- Daclizumab Subcutaneous-Clarithromycin
- Daclizumab Subcutaneous-Clarithromycin ER
- Daclizumab Subcutaneous-Clarithromycin Extended-Release Tablets
- Daclizumab Subcutaneous-Clarithromycin Oral Suspension